Copper(i) targeting in the Alzheimer's disease context: A first example using the biocompatible PTA ligand

35Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Copper(i) coordinating ligands in the Alzheimer's disease context have remained unexplored, despite the biological relevance of this redox state of the copper ion. Here, we show that the PTA ligand can remove copper from Aβ, prevent reactive oxygen species production and oligomer formation, two deleterious events in the disease's etiology.

Cite

CITATION STYLE

APA

Atrián-Blasco, E., Cerrada, E., Conte-Daban, A., Testemale, D., Faller, P., Laguna, M., & Hureau, C. (2015). Copper(i) targeting in the Alzheimer’s disease context: A first example using the biocompatible PTA ligand. Metallomics, 7(8), 1229–1232. https://doi.org/10.1039/c5mt00077g

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free